

Has your doctor asked you to take a Chromogranin A (CgA) test?
This might be the first time you’ve heard of this type of test, as it’s not part of routine blood work. Instead, it’s a specialized test used to detect certain types of tumors.In this article from Dalili Medical, we provide you with a comprehensive guide to understanding the CgA test:
What is it? When is it requested? What do the results mean? And why is it considered an important marker in diagnosing neuroendocrine tumors?
The Chromogranin A (CgA) test is a blood test used to measure the level of a protein secreted by neuroendocrine cells—specialized cells found in the nervous system and endocrine glands that produce hormones.
An elevated CgA level in the blood may indicate the presence of a neuroendocrine tumor (NET)—a rare type of tumor that most commonly arises in the digestive tract, pancreas, or lungs.
Your doctor may order a Chromogranin A test in the following cases:
When a neuroendocrine tumor (NET) is suspected.
To monitor an already diagnosed NET patient.
To evaluate treatment effectiveness, such as after surgery or chemotherapy.
As part of post-treatment follow-up to detect any recurrence of the tumor.
A simple venous blood sample is drawn.
Fasting is not always required, but the test is usually done in the morning.
It is recommended to stop taking certain medications (like acid reducers) before the test, based on your doctor’s advice.
The sample is sent to a lab, and results are typically available within 1–2 days.
Yes. It’s important to inform your doctor about any medications you're taking, especially:
Proton pump inhibitors (PPIs) such as omeprazole or esomeprazole, which may increase CgA levels and lead to false-positive results.
Certain heart medications.
Severe liver or inflammatory conditions.
It's often advised to discontinue PPIs for at least two weeks before the test, if possible.
Values vary slightly between labs, but are usually below 100 ng/mL.
May indicate:
Presence of a neuroendocrine tumor (NET), such as:
Carcinoid tumor
Gastrinoma, insulinoma, or glucagonoma
NETs in the pancreas, stomach, or lungs
Chronic kidney disease
Severe liver disease or inflammation
Long-term use of acid-suppressing medications (PPIs)
Generally not clinically significant, but may suggest a positive response to treatment or tumor regression.
NETs are rare tumors that arise from cells with both nervous and hormonal functions.
They usually grow slowly, but can produce hormones that lead to troubling symptoms like:
Chronic diarrhea
Facial flushing
Blood sugar imbalances
They range from benign to malignant, and CgA testing is one of the most important markers for detecting and monitoring these tumors.
❌ Not necessarily. Other causes include:
Use of proton pump inhibitors (PPIs)
Liver or kidney disease
Severe inflammatory conditions
❌ No. It serves as an initial indicator, but should be followed by:
Imaging tests (CT, MRI, PET scans)
Biopsies
Other hormone-related tests
✅ Yes. The test is highly useful for tracking tumor progression, treatment response, and detecting recurrence.
It’s rarely used in children because NETs are very uncommon in childhood, but it may be performed if medically necessary.
If your CgA test shows elevated levels, don’t panic. A high result doesn’t automatically mean you have a tumor.
You should always consult a specialist in neuroendocrine or gastrointestinal tumors, and follow up with additional diagnostic tests.
The Chromogranin A (CgA) test is a valuable tool for detecting and monitoring neuroendocrine tumors (NETs).
Though not a routine test, it offers essential insight in specific medical situations—especially if there are concerning symptoms or a prior diagnosis.If your doctor recommends this test, be sure to follow preparation instructions carefully, and review the results with a qualified specialist.